Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: A study of 10,012 cases from a nationwide working group

Oncologist

Volumn 18, Issue 10, 2013, Pages 1101-1107

  Li, Shuang ^a   Hu, Ting ^a   Lv, Weiguo ^b   Zhou, Hang ^a   Li, Xiong ^a   Yang, Ru ^a   Jia, Yao ^a   Huang, Kecheng ^a   Chen, Zhilan ^a   Wang, Shaoshuai ^a   Tang, FangXu ^a   Zhang, Qinghua ^a   Shen, Jian ^a   Zhou, Jin ^a   Xi, Ling ^a   Deng, Dongrui ^a   Wang, Hui ^a   Wang, Shixuan ^a   Xie, Xing ^b   Ma, Ding ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Women's Reproductive Health Laboratory of Zhejiang Province   (China)

Author keywords

Cervical cancer; Clinical feature; Surgery; Survival rate; Therapeutic strategies

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CHEMORADIOTHERAPY; CHINA; CONSERVATIVE TREATMENT; CORPUS UTERI PRESERVATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARIAN PRESERVATION; OVARIECTOMY; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UTERINE CERVIX CANCER; MIDDLE AGED; PATHOLOGY; UTERINE CERVICAL NEOPLASMS;

ADULT; CHEMOTHERAPY, ADJUVANT; CHINA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; UTERINE CERVICAL NEOPLASMS;

EID: 84886020338     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0123     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008 CA Cancer J Clin 2008;58:71-96.
2. Cai HB, Liu XM, Huang Y et al. Trends in cervical cancer in young women in Hubei, China Int J Gynecol Cancer 2010;20:1240-1243.
3. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-5812.
4. Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 2009;105:107-108.
5. Jones WB, Shingleton HM, Russell A et al. Patterns of care for invasive cervical cancer. Results ofa national survey of 1984 and 1990. Cancer 1995;76: 1934-1947.
6. Eifel PJ, Winter K, MorrisMet al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol 2004;22:872-880.
7. Powell ME. Modern radiotherapy and cervical cancer. Int J Gynecol Cancer 2010;20:S49-S51.
8. FrumovitzM, SunCC, Schover LR et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 2005;23:7428-7436.
9. Hu T, Li S, Chen Y et al. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria. Eur J Cancer 2012;48:2353-2360.
10. Ptackova B. Carcinoma cervicis uteri. Treatment results from the period 1953-1968 Neoplasma 1976;23:215-221.
11. PiverMS, ChungWS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975;46:507-510.
12. Ruponen S. Diagnostic and therapeutic aspects of cervical carcinoma. Based on the material of 991 cases. Acta Obstet Gynecol Scand Suppl 1977;68:1-42.
13. Jimenez J, Alert J, Beldarrain L et al. Carcinoma of the uterine cervix. Results of treatment in 2 248 cases. Acta Radiol Oncol Radiat Phys Biol 1979;18: 465-469.
14. Ylinen K, Nieminen U, ForssMet al. Changing pattern of cervical carcinoma: A report of 709 cases of invasive carcinoma treated in 1970-1974. Gynecol Oncol 1985;20:378-386.
15. de Rijke JM, van der Putten HW, Lutgens LC et al. Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of the Netherlands, 1986-1996. Eur J Cancer 2002;38:2041-2047.
16. Howell E, Chen YT, Moradi M et al. Cervical cancer practice patterns and appropriateness of therapy. AmJ Obstet Gynecol 2000;183:407-413.
17. Movva S, Noone AM, BanerjeeMet al. Racial differences in cervical cancer survival in the Detroit metropolitan area. Cancer 2008;112:1264-1271.
18. WangPD, Lin RS. Epidemiology of cervical cancer in Taiwan. Gynecol Oncol 1996;62:344-352.
19. Devesa SS, Young JL Jr. Brinton LA et al. Recent trends in cervix uteri cancer. Cancer 1989;64:2184-2190.
20. Geirsson G, Johannesson G, Tulinius H. Tumoursin Iceland. 5. Malignanttumoursof the cervix uteri Histological types, clinical stages and the effect of mass screening Acta Pathol Microbiol Immunol Scand A 1982;90:139-143.
21. van Nagell JR Jr. Powell DE, Gallion HH et al. Small cell carcinoma of the uterine cervix. Cancer 1988;62:1586-1593.
22. Watson M, Saraiya M, Benard V et al. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008;113:2855-2864.
23. Takac I, Ursic-Vrscaj M, Repse-Fokter A et al. Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia. Eur J Obstet Gynecol Reprod Biol 2008;140:82-89.
24. Patel DA, Barnholtz-Sloan JS, Patel MK et al. A population-based study of racial and ethnic differences in survival amongwomenwith invasive cervical cancer: Analysis of Surveillance, Epidemiology, and End Results data Gynecol Oncol 2005;97:550-558.
25. Shah M, Lewin SN, Deutsch I et al. Therapeutic role of lymphadenectomy for cervical cancer. Cancer 2011;117:310-317.
26. Hakama M, West R. Cervical cancer in Finland and South Wales: Implications of end results data on the natural history. J Epidemiol Community Health 1980;34:14-18.
27. Gad C. Treatment and survival in 631 patients with invasive carcinoma of the cervix. Br J Obstet Gynaecol 1976;83:560-566.
28. Bates JH, Hofer BM, Parikh-Patel A. Cervical cancer incidence, mortality, and survival among Asian subgroups in California, 1990-2004. Cancer 2008;113:2955-2963.
29. Toita T, Mitsuhashi N, Teshima T et al. Postoperative radiotherapy for uterine cervical cancer: Results of the 1995-1997 patterns of care process survey in Japan. Jpn J Clin Oncol 2004;34:99-103.
30. Ioka A, Ito Y, Tsukuma H. Factors relating to poor survival rates of aged cervical cancer patients: A population-based study with the relative survival model in Osaka, Japan Asian Pac J Cancer Prev 2009; 10:457-462.
31. Shi JF, Canfell K, LewJB et al. Theburden of cervical cancer in China: Synthesis of the evidence. Int J Cancer 2012;130:641-652.
32. Boo YK, Kim WC, Lee HY et al. Incidence trends in invasive uterine cervix cancer and carcinoma in situ in Incheon, South Korea Asian Pac J Cancer Prev 2011;12:1985-1988.
33. Murthy NS, Chaudhry K, Saxena S. Trends in cervical cancer incidence-Indian scenario. Eur J Cancer Prev 2005;14:513-518.
34. Zhao EF, Bao L, Li C et al. Changes in epidemiology and clinical characteristics of cervical cancer over the past 50 years. Di Yi Jun Yi Da Xue Xue Bao 2005;25:605-609.
35. Quinn MA, Benedet JL, Odicino F et al. Carcinomaof the cervix uteri. FIGO26thannual reporton the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95(Suppl 1):S43-S103.
36. ZhaoFH, TiggelaarSM, HuSY et al. Amulti-center survey of age of sexual debut and sexual behavior in Chinese women: Suggestions for optimal age of human papillomavirus vaccination in China. Cancer Epidemiol 2012;36:384-390.
37. Singh GK. Rural-urban trends and patterns in cervical cancer mortality, incidence, stage, and survival in the United States, 1950-2008. J Community Health 2012;37:217-223.
38. Bray F, Loos AH, McCarron P et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005;14:677-686.
39. Hu T, WuL, Xing H et al. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: A multicenter retrospective study and meta-analysis. Ann Surg Oncol 2013;20:881-890.